Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2630
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy ; day:4 ; month:10 ; year:2019 ; pages:1-8
International ophthalmology ; (4.10.2019), 1-8
- Urheber
-
Castagna, I.
Roszkowska, A. M.
Alessandrello, F.
Oliverio, G. W.
Tumminello, G.
Gallizzi, R.
Conti, G.
Aragona, P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10792-019-01184-8
- URN
-
urn:nbn:de:101:1-2020020801115385767809
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Castagna, I.
- Roszkowska, A. M.
- Alessandrello, F.
- Oliverio, G. W.
- Tumminello, G.
- Gallizzi, R.
- Conti, G.
- Aragona, P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF